{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:05:46Z","timestamp":1779163546591,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Ministry of Education's Chunhui Plan","award":["202200476"],"award-info":[{"award-number":["202200476"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81872079"],"award-info":[{"award-number":["81872079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science Foundation of Tianjin","award":["2022ZD070"],"award-info":[{"award-number":["2022ZD070"]}]},{"name":"the Hebei Province Traditional Chinese Medicine Research Project","award":["T2025066"],"award-info":[{"award-number":["T2025066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03659-0","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T18:26:03Z","timestamp":1765477563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CEACAM6 regulates glycolytic metabolism in bladder cancer cell by controlling ENO1 stability"],"prefix":"10.1186","volume":"30","author":[{"given":"Pu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changchang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Altuwaijri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"3659_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3659_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"key":"3659_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076743","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, et al. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024. https:\/\/doi.org\/10.1136\/bmj-2023-076743.","journal-title":"BMJ"},{"issue":"1","key":"3659_CR4","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s42003-024-07343-7","volume":"7","author":"S Liu","year":"2024","unstructured":"Liu S, Feng C, Tan L, et al. Single-cell dissection of multifocal bladder cancer reveals malignant and immune cells variation between primary and recurrent tumor lesions. Commun Biol. 2024;7(1):1659.","journal-title":"Commun Biol"},{"issue":"27","key":"3659_CR5","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1200\/JCO-25-00718","volume":"43","author":"MD Galsky","year":"2025","unstructured":"Galsky MD, Ballas L, Kamat AM. Muscle-invasive bladder cancer: a watershed moment. J Clin Oncol. 2025;43(27):3041\u201351.","journal-title":"J Clin Oncol"},{"key":"3659_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2407-7-2","volume":"7","author":"RD Blumenthal","year":"2007","unstructured":"Blumenthal RD, Leon E, Hansen HJ, et al. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer. 2007;7:2.","journal-title":"BMC Cancer"},{"issue":"1","key":"3659_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbrc.2004.03.018","volume":"317","author":"MS Duxbury","year":"2004","unstructured":"Duxbury MS, Ito H, Ashley SW, et al. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components. Biochem Biophys Res Commun. 2004;317(1):133\u201341.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3659_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12964-025-02233-9","volume":"23","author":"Q Wu","year":"2025","unstructured":"Wu Q, Siddharth S, Verma D, et al. TRIM29 upregulation contributes to chemoresistance in triple negative breast cancer via modulating S100P-\u03b2-catenin axis. Cell Commun Signal. 2025;23(1):244.","journal-title":"Cell Commun Signal"},{"key":"3659_CR9","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1038\/s41598-017-11482-9","volume":"7","author":"M Zang","year":"2017","unstructured":"Zang M, Hu L, Cao S, et al. Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients. Sci Rep. 2017;7:10773.","journal-title":"Sci Rep"},{"issue":"6","key":"3659_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006609","volume":"11","author":"D Restle","year":"2023","unstructured":"Restle D, Dux J, Li X, et al. Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma. J Immunother Cancer. 2023;11(6):e006609.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"3659_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/sj.bjc.6603276","volume":"95","author":"K Ieta","year":"2006","unstructured":"Ieta K, Tanaka F, Utsunomiya T, et al. CEACAM6 gene expression in intrahepatic cholangiocarcinoma. Br J Cancer. 2006;95(4):532\u201340.","journal-title":"Br J Cancer"},{"key":"3659_CR12","first-page":"e217","volume":"17","author":"MT Rodia","year":"2018","unstructured":"Rodia MT, Solmi R, Pasini F, et al. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result. Clin Colorectal Cancer. 2018;17:e217\u201328.","journal-title":"Clin Colorectal Cancer"},{"key":"3659_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/abbs\/gmu001","volume":"46","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Zang M, Li J, et al. CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer. Acta Biochim Biophys Sin. 2014;46:283\u201390.","journal-title":"Acta Biochim Biophys Sin"},{"key":"3659_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/cas.13437","volume":"109","author":"B Rizeq","year":"2018","unstructured":"Rizeq B, Zakaria Z, Ouhtit A. Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. Cancer Sci. 2018;109:33\u201342.","journal-title":"Cancer Sci"},{"issue":"1","key":"3659_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41417-024-00846-9","volume":"32","author":"X Mao","year":"2025","unstructured":"Mao X, Liu T, Yu S, et al. CEACAM6 facilitates gastric cancer progression through upregulating SLC27A2. Cancer Gene Ther. 2025;32(1):51\u201360.","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"3659_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.trecan.2024.08.001","volume":"10","author":"LM Perez","year":"2024","unstructured":"Perez LM, Venugopal SV, Martin AS, et al. Mechanisms governing lineage plasticity and metabolic reprogramming in cancer. Trends Cancer. 2024;10(11):1009\u201322.","journal-title":"Trends Cancer"},{"key":"3659_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429308361240823061634","volume":"17","author":"L Qiong","year":"2024","unstructured":"Qiong L, Shuyao X, Shan X, et al. Recent advances in the glycolytic processes linked to tumor metastasis. Curr Mol Pharmacol. 2024;17:e18761429308361.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"3659_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1566523222666220830150446","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Huang H, Wu S, et al. The role of RNA m6A modification in cancer glycolytic reprogramming. Curr Gene Ther. 2023;23(1):51\u20139.","journal-title":"Curr Gene Ther"},{"key":"3659_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101076","volume":"58","author":"M Cordani","year":"2024","unstructured":"Cordani M, Michetti F, Zarrabi A, et al. The role of glycolysis in tumorigenesis: from biological aspects to therapeutic opportunities. Neoplasia. 2024;58:101076.","journal-title":"Neoplasia"},{"key":"3659_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/0008-5472.CAN-21-0403","volume":"82","author":"Y Xia","year":"2022","unstructured":"Xia Y, Wang X, Liu Y, et al. PKM2 is essential for bladder cancer growth and maintenance. Cancer Res. 2022;82:571\u201385.","journal-title":"Cancer Res"},{"key":"3659_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jhep.2024.05.034","volume":"81","author":"Y Lao","year":"2024","unstructured":"Lao Y, Cui X, Xu Z, et al. Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma. J Hepatol. 2024;81:847\u201361.","journal-title":"J Hepatol"},{"issue":"9","key":"3659_CR22","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.7150\/thno.40860","volume":"10","author":"T Hu","year":"2020","unstructured":"Hu T, Liu H, Liang Z, et al. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis. Theranostics. 2020;10(9):4056\u201372.","journal-title":"Theranostics"},{"key":"3659_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122974","volume":"355","author":"J Wang","year":"2024","unstructured":"Wang J, Ren J, Tu X, et al. ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner. Life Sci. 2024;355:122974.","journal-title":"Life Sci"},{"issue":"1","key":"3659_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-025-03325-7","volume":"44","author":"D Shen","year":"2025","unstructured":"Shen D, Yu X, Fan X, et al. CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis. J Exp Clin Cancer Res. 2025;44(1):63.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3659_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/0113892029255941231014142050","volume":"24","author":"J Qiu","year":"2023","unstructured":"Qiu J, Zhou T, Wang D, et al. Pan-cancer analysis identifies AIMP2 as a potential biomarker for breast cancer. Curr Genomics. 2023;24(5):307\u201329.","journal-title":"Curr Genomics"},{"issue":"9","key":"3659_CR26","first-page":"12","volume":"20","author":"S Wang","year":"2024","unstructured":"Wang S, Xie C, Hu H, et al. iTRAQ-based proteomic analysis unveils NCAM1 as a novel regulator in doxorubicin-induced cardiotoxicity and DT-010-exerted cardioprotection. Curr Pharm Anal. 2024;20(9):12.","journal-title":"Curr Pharm Anal"},{"key":"3659_CR27","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429254358231120135400","volume":"17","author":"W Wang","year":"2024","unstructured":"Wang W, Xu X, Yang M, et al. Ginsenoside compound K reduces psoriasis-related inflammation by activation of the glucocorticoid receptor in keratinocytes. Curr Mol Pharmacol. 2024;17:e18761429254358.","journal-title":"Curr Mol Pharmacol"},{"issue":"7","key":"3659_CR28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/0109298665305114240718072029","volume":"31","author":"S Tian","year":"2024","unstructured":"Tian S, Chen M, Jing W, et al. MiR-1204 positioning in 8q24.21 involved in the tumorigenesis of colorectal cancer by targeting MASPIN. Protein Peptide Lett. 2024;31(7):544\u201358.","journal-title":"Protein Peptide Lett"},{"issue":"2","key":"3659_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/0115665232258527230919071328","volume":"24","author":"Y Ning","year":"2024","unstructured":"Ning Y, Zhou X, Wang G, et al. Exosome miR-30a-5p regulates glomerular endothelial cells\u2019 EndMT and angiogenesis by modulating Notch1\/VEGF signaling pathway. Curr Gene Ther. 2024;24(2):159\u201377.","journal-title":"Curr Gene Ther"},{"issue":"8038","key":"3659_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","volume":"635","author":"A Redenti","year":"2024","unstructured":"Redenti A, Im J, Redenti B, et al. Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature. 2024;635(8038):453\u201361.","journal-title":"Nature"},{"issue":"8059","key":"3659_CR31","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41586-025-08591-1","volume":"640","author":"X Zhi","year":"2025","unstructured":"Zhi X, Wu F, Qian J, et al. Nociceptive neurons promote gastric tumour progression via a CGRP-RAMP1 axis. Nature. 2025;640(8059):802\u201310.","journal-title":"Nature"},{"issue":"1","key":"3659_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1186\/s12967-024-05847-8","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Liu L, Li B. Role of ENO1 and its targeted therapy in tumors. J Transl Med. 2024;22(1):1025.","journal-title":"J Transl Med"},{"key":"3659_CR33","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1158\/0008-5472.CAN-20-3543","volume":"81","author":"HJ Li","year":"2021","unstructured":"Li HJ, Ke FY, Lin CC, et al. ENO1 promotes lung cancer metastasis via HGFR and WNT signaling-driven epithelial-to-mesenchymal transition. Cancer Res. 2021;81:4094\u2013109.","journal-title":"Cancer Res"},{"issue":"3","key":"3659_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13577-025-01215-w","volume":"38","author":"X Liu","year":"2025","unstructured":"Liu X, Ren H, Wang A, et al. SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1. Hum Cell. 2025;38(3):88.","journal-title":"Hum Cell"},{"issue":"6","key":"3659_CR35","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.7150\/ijbs.109192","volume":"21","author":"S Xiao","year":"2025","unstructured":"Xiao S, Jiang S, Wen C, et al. EMC2 promotes breast cancer progression and enhances sensitivity to PDK1\/AKT inhibition by deubiquitinating ENO1. Int J Biol Sci. 2025;21(6):2629\u201346.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3659_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eururo.2023.10.010","volume":"85","author":"PJ Hensley","year":"2024","unstructured":"Hensley PJ, Choudhury A, Khaki AR, et al. The 2023 European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: a critical appraisal. Eur Urol. 2024;85(1):32\u20134.","journal-title":"Eur Urol"},{"issue":"3-4","key":"3659_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-013-9444-6","volume":"32","author":"N Beauchemin","year":"2013","unstructured":"Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 2013;32(3\u20134):643\u201371.","journal-title":"Cancer Metastasis Rev"},{"issue":"24","key":"3659_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jare.2020.03.001","volume":"3","author":"E Ferlizza","year":"2020","unstructured":"Ferlizza E, Solmi R, Miglio R, et al. Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects. J Adv Res. 2020;3(24):99\u2013107.","journal-title":"J Adv Res"},{"key":"3659_CR39","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/15384101.2022.2041354","volume":"10","author":"C Chu","year":"2022","unstructured":"Chu C, Liu X, Zhao Z, et al. Circ-0008035 promotes the progression of gastric cancer via the regulation of miR-1256\/CEACAM6 axis. Cell Cycle. 2022;10:1091\u2013102.","journal-title":"Cell Cycle"},{"issue":"1","key":"3659_CR40","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3892\/or.2015.4338","volume":"35","author":"L Yan","year":"2016","unstructured":"Yan L, Wang Y, Wang ZZ, et al. Cell motility and spreading promoted by CEACAM6 through cyclin D1\/CDK4 in human pancreatic carcinoma. Oncol Rep. 2016;35(1):418\u201326.","journal-title":"Oncol Rep"},{"issue":"8","key":"3659_CR41","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, et al. The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int J Biol Sci. 2024;20(8):3113\u201325.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3659_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12672-024-01053-6","volume":"15","author":"D Zhao","year":"2024","unstructured":"Zhao D, Cai F, Liu X, et al. CEACAM6 expression and function in tumor biology: a comprehensive review. Discov Oncol. 2024;15(1):186.","journal-title":"Discov Oncol"},{"issue":"7","key":"3659_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101057","volume":"14","author":"SJ Wu","year":"2021","unstructured":"Wu SJ, Arundhathi A, Wang HC, et al. Migration and invasion of NSCLC suppressed by the downregulation of Src\/focal adhesion kinase using single, double and tetra domain anti- CEACAM6 antibodies. Transl Oncol. 2021;14(7):101057.","journal-title":"Transl Oncol"},{"issue":"11","key":"3659_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112908","volume":"9","author":"M Zang","year":"2014","unstructured":"Zang M, Zhang B, Zhang Y, et al. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K\/AKT signaling pathway. PLoS ONE. 2014;9(11):e112908.","journal-title":"PLoS ONE"},{"issue":"1","key":"3659_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41698-025-00910-z","volume":"9","author":"MY Zheng","year":"2025","unstructured":"Zheng MY, Lin YT, Kuo YS, et al. Cytokine and epigenetic regulation of CEACAM6 mediates EGFR-driven signaling and drug response in lung adenocarcinoma. NPJ Precis Oncol. 2025;9(1):115.","journal-title":"NPJ Precis Oncol"},{"issue":"20","key":"3659_CR46","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","volume":"188","author":"CX Zhang","year":"2025","unstructured":"Zhang CX, Huang RY, Sheng G, Thiery JP. Epithelial-mesenchymal transition. Cell. 2025;188(20):5436\u201386.","journal-title":"Cell"},{"issue":"1","key":"3659_CR47","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.13157","volume":"23","author":"C Liu","year":"2022","unstructured":"Liu C, Wang M, Lv H, et al. CEACAM6 promotes cholangiocarcinoma migration and invasion by inducing epithelial-mesenchymal transition through inhibition of the SRC\/PI3K\/AKT signaling pathway. Oncol Lett. 2022;23(1):39.","journal-title":"Oncol Lett"},{"key":"3659_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101402","volume":"20","author":"EY Kim","year":"2022","unstructured":"Kim EY, Cha YJ, Jeong S, et al. Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas. Transl Oncol. 2022;20:101402.","journal-title":"Transl Oncol"},{"issue":"1","key":"3659_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13062-023-00420-7","volume":"18","author":"L Gan","year":"2023","unstructured":"Gan L, Zhao S, Gao Y, et al. N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression. Biol Direct. 2023;18(1):64.","journal-title":"Biol Direct"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03659-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:03:41Z","timestamp":1765533821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03659-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03659-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants in this investigation were reviewed and obtained the approval of the Ethics Committee of the Second Hospital of Tianjin Medical University (KY2024K038). Animal experiments adhered to the Animal Experiment Ethics Committee of Tianjin University of Traditional Chinese Medicine (TCM-LAEC2024098w1629).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Each author made contributions during manuscript preparation or amendment and approved the submitted version.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1233"}}